Identifying erlotinib-sensitive non-small cell lung carcinoma tumors in mice using [(11)C]erlotinib PET

BACKGROUND: Non-small cell lung carcinoma (NSCLC) represents approximately 80% of lung cancer cases, and over 60% of these tumors express the epidermal growth factor receptor (EGFR). Activating mutations in the tyrosine kinase (TK) domain of the EGFR are detected in 10% to 30% of NSCLC patients, and...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:EJNMMI Res
Hoofdauteurs: Abourbeh, Galith, Itamar, Batel, Salnikov, Olga, Beltsov, Sergey, Mishani, Eyal
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Springer Berlin Heidelberg 2015
Onderwerpen:
Original Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4385014/
https://ncbi.nlm.nih.gov/pubmed/25853010
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13550-014-0080-0
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items